REDACTED JA_Redacted.pdf

VHAPM Part 813.106 Page 1 of 2 Original Date: 08/30/17 Revision 02 Eff Date: 03/31/2020

DEPARTMENT OF VETERANS AFFAIRS

Justification for Single Source Awards IAW FAR 13.106-1 For

Over Micro-Purchase Threshold but Not Exceeding the SAT ($250K)

Acquisition Plan Action ID: 36C244-21-AP-3818

1. Contracting Activity: Department of Veterans Affairs, VISN 04, Wilkes-Barre VA Medical Center, 1111 East End Blvd., Wilkes-Barre, PA 18711. PR: 693-21-3-179-0091.

2. Brief Description of Supplies/ Services required and the intended use/Estimated Amount:

This is a Brand Name requirement for two Bayer Medrad Stellant Injectors to be located at the Wilkes-Barre VA Medical Center. This equipment will be utilized in the Imaging Department for injecting radio-opaque contrast media into the body to enhance the visibility of tissues for a medical imaging procedure.

3. Unique characteristics that limit availability to only one source, with the reason no other supplies or services can be used: The Bayer Medrad Stellant Injection System is the first and only CT injection system currently cleared for use with the Contrast Enhanced Mammography (CEM). CEM can allow for better visualization of abnormalities in breast tissue that may not be visible with conventional mammography.

These injectors are

Digital Imaging and Communications in Medicine (DICOM) complaint and compatible with Vista integration into the system scanners. The Medrad Stellant Injection System are interchangeable with imaging rooms and network data located at Wilkes-Barre VA Medical Center.

4. Description of market research conducted and results or statement why it was not conducted:

All of the mandatory contract vehicles, the Strategic Acquisition Center (SAC) and Medical Surgical Prime Vendor (MSPV), resulted in no findings. The GSA contract libraries were searched and resulted in no findings. The Vendor Information Pages (VIP) was searched using NAICS 339112 and keywords Medrad Stellant and resulted in one result, authorized distributor 1st American Medical Distributors (SDVOSB). However, as stated above, the OEM confirmed a total of 3 authorized SDVOSBs as resellers for the Bayer Medrad Stellant Injection System.

During Market Research, a Request for Information (RFI 36C24421Q0872) was posted to Federal Contract Opportunities from June 23, 2021 to June 28, 2021 12pm ET. A total of three responses were received.